# Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients

> **NCT04410471** · — · UNKNOWN · sponsor: **Magdalena Salcedo** · enrollment: 300 (estimated)

## Conditions studied

- Liver Transplant Infection
- Covid19
- Mortality
- Immune Response

## Interventions

- **DIAGNOSTIC_TEST:** CLIA of IgG and IgM against SARS-Cov-2

## Key facts

- **NCT ID:** NCT04410471
- **Lead sponsor:** Magdalena Salcedo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-29
- **Primary completion:** 2020-05-29
- **Final completion:** 2021-06-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04410471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04410471, "Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04410471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*